These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 4724706)
1. Effect of growth hormone and thyroxine on the contractile properties of dystrophic muscle. Berk SL; Ullrick WC Experientia; 1973; 29(7):809-10. PubMed ID: 4724706 [No Abstract] [Full Text] [Related]
2. Human growth hormone and estrogens in boys with Duchenne muscular dystrophy. Chyatte SB; Rudman D; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS Arch Phys Med Rehabil; 1973 Jun; 54(6):248-53. PubMed ID: 4708006 [No Abstract] [Full Text] [Related]
3. [Treatment problems using anabolic steroids in progressive muscular dystrophy]. Badalian LO; Temin PA; Mukhin KIu Klin Med (Mosk); 1984 Nov; 62(11):23-9. PubMed ID: 6394898 [No Abstract] [Full Text] [Related]
4. Effect of growth hormone and thyroxinon isometric contractile mechanics of cardiac muscle. Minelli R; Korecky B Can J Physiol Pharmacol; 1969 Jun; 47(6):545-52. PubMed ID: 5797395 [No Abstract] [Full Text] [Related]
5. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone. Rudman D; Kutner MH; Chawla RK; Goldsmith MA J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201 [TBL] [Abstract][Full Text] [Related]
6. Contractile properties of skeletal muscle in dystrophic mice. Taylor RG; Fowler WM; Mason DT; Spann JF Arch Phys Med Rehabil; 1971 Nov; 52(11):511-5. PubMed ID: 5121040 [No Abstract] [Full Text] [Related]
7. Hyper-responsiveness of patients with limb-girdle dystrophy to human growth hormone. Rudman D; Chyatte SB; Gerron GG; O'Beirne I; Barlow J J Clin Endocrinol Metab; 1972 Aug; 35(2):256-60. PubMed ID: 5072356 [No Abstract] [Full Text] [Related]
8. Muscle diseases: the muscular dystrophies. McNally EM; Pytel P Annu Rev Pathol; 2007; 2():87-109. PubMed ID: 18039094 [TBL] [Abstract][Full Text] [Related]
9. Tropomyosin and troponin in normal and dystrophic human muscle. Samaha FJ Arch Neurol; 1972 Jun; 26(6):547-50. PubMed ID: 5030788 [No Abstract] [Full Text] [Related]
10. Effect of growth hormone and thyroxine on growth and chemical composition of muscle, bone and other tissues in thyroidectomized-hypophysectomized rats. SCOW RO Am J Physiol; 1959 Apr; 196(4):859-65. PubMed ID: 13637230 [No Abstract] [Full Text] [Related]
11. Effects of denervation on normal and dystrophic muscle: DNA and nucleotide enzymes. McCaman MW; McCaman RE Am J Physiol; 1965 Sep; 209(3):495-500. PubMed ID: 4220896 [No Abstract] [Full Text] [Related]
13. Leucine aminopeptidase activity in muscles of dystrophic mice. Bois P Experientia; 1964 Mar; 20(3):140-1. PubMed ID: 5853679 [No Abstract] [Full Text] [Related]
14. Muscle wasting in muscular dystrophy: decreased protein synthesis or increased degradation? Griggs RC; Rennie MJ Ann Neurol; 1983 Feb; 13(2):125-32. PubMed ID: 6338807 [No Abstract] [Full Text] [Related]
15. Observations on the efficiency of dystrophic muscle in vitro. Hofmann WW; Ruprecht EO J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):565-73. PubMed ID: 4731327 [TBL] [Abstract][Full Text] [Related]
16. Agents which affect excitation-contraction coupling in normal and dystrophic muscle. Brust M Fed Proc; 1969; 28(5):1649-56. PubMed ID: 5817975 [No Abstract] [Full Text] [Related]
17. Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption. Fougerousse F; Gonin P; Durand M; Richard I; Raymackers JM Muscle Nerve; 2003 May; 27(5):616-23. PubMed ID: 12707983 [TBL] [Abstract][Full Text] [Related]
18. NADH-2 cytochrome C reductase and cytochrome C oxidase in experimental muscle disorders. Dobson HL; Kasahara M Tex Rep Biol Med; 1964 Dec; 22():Suppl 1:890+. PubMed ID: 4284089 [No Abstract] [Full Text] [Related]